Collaborations

Cellartis participates in pioneering stem cell collaboration in Scotland

Published in Lab Law Weekly, February 16th, 2007

The Gothenburg, Sweden, based biotech company Cellartis AB and its partners ITI Life Sciences and University of Glasgow announced an extensive UKP 9.5 million R&D programme to develop human stem cells for pharmaceutical research.

The funding of the programme was made by ITI Life Sciences.

"This is an immensely exciting programme, and we are very much looking forward to participating in it. This important collaboration is in line with our strategic goal of scaling up our human embryonic stem cell technology," commented Mats Lundwall, CEO of Cellartis.

"Life science research in Scotland, particularly in the stem cell area, is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2007-02-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry